| Gene symbol | AFP | Synonyms | AFPD, FETA, HPAFP | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | alpha fetoprotein | ||||
| GTO ID | GTC2120 |
| Trial ID | NCT03965546 |
| Disease | Liver Cancer |
| Altered gene | AFP |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | ET140202 T cells |
| HLA | HLA-A*02 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Advanced Liver Cancer |
| Year | 2019 |
| Country | China |
| Company sponsor | First Affiliated Hospital Xi'an Jiaotong University |
| Other ID(s) | 2019(ZD13) |
| Vector information | |||
|
|||
| Cohort1: ET140202-T cell | |||||||||
|
|||||||||
| Cohort2: ET140202-T cell_Sorafenib | |||||||||
|
|||||||||
| Cohort3: ET140202-T cell_TAE | |||||||||
|
|||||||||